Found 1694 results for "cancer"
For decades, vitamin D's immune benefits have been described in broad strokes — anti-inflammatory, gut-protective — without a clear molecular blueprint…
As gonorrhea quietly becomes untreatable with conventional antibiotics, a fundamentally different weapons platform is entering the conversation — one borrowed…
Metabolic reprogramming is now recognized as a hallmark of aggressive cancers, but pinpointing the molecular switches that redirect cellular metabolism toward…
Understanding how the body regulates red blood cell production under varying oxygen conditions has implications far beyond anemia treatment — it touches…
The immune system's failure to sustain its attack on tumors and chronic viral infections like HIV shares more common ground than previously appreciated — and…
Cellular senescence in glioblastoma (WHO Grade IV) is not the tumor-suppressive endpoint it represents in normal tissue. In malignant gliomas, senescence…
Cholangiocarcinoma — bile duct cancer — carries one of the bleakest prognoses in oncology, with five-year survival rates below 10% and limited targeted…
Amyotrophic lateral sclerosis remains one of the most devastating neurodegenerative diseases, with no cure and poorly understood environmental triggers…
For patients with cancers that have resisted conventional systemic therapies, the ability to simultaneously image and destroy tumor cells using the same…
Nearly one-third of stage III colorectal cancer patients relapse despite completing standard adjuvant chemotherapy — a stubborn failure rate that has driven…
For the hundreds of thousands of patients worldwide living with EGFR-mutant non-small cell lung cancer, osimertinib has become a standard first-line therapy…
Immunotherapy resistance remains one of oncology's most intractable problems, affecting a substantial proportion of cancer patients who initially respond to…
For the roughly one-third of men with advanced prostate cancer who eventually exhaust every available androgen-targeting drug, the biology driving that final…
Access to high-quality surgical oncology care remains one of the most persistent structural inequities in American healthcare. Rural patients with cancer…
One of the most persistent frustrations in oncology is that even the best immune checkpoint therapies fail in a substantial fraction of patients — and the…
Among the most consequential questions in longevity research is whether specific dietary signals — rather than broad caloric reduction — can be targeted to…
Pancreatic ductal adenocarcinoma remains one of oncology's most lethal challenges, with five-year survival rates still below 13%. A newly described molecular…
Heart failure driven by chronic pressure overload — as occurs in longstanding hypertension or aortic stenosis — remains one of the leading causes of…
Triple-negative breast cancer represents one of oncology's most stubborn challenges — a subtype defined by the absence of estrogen, progesterone, and HER2…
Triple-negative breast cancer remains one of oncology's most frustrating challenges precisely because it lacks the molecular handles — hormone receptors, HER2…